Asia Pacific Intraocular Lens Market Size, Share, Trends & Growth Forecast Report By Material, Type, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) – Industry Analysis From (2025 to 2033)

Updated On: June, 2024
ID: 5242
Pages: 130

Asia Pacific Intraocular Lens Market Size

The size of the Asia Pacific intraocular lens market was valued at USD 0.94 billion in 2024. This market is expected to grow at a CAGR of 6.8% from 2025 to 2033 and be worth USD 1.69 billion by 2033 from USD 1 billion in 2025. 

By 2033, the Asia Pacific intraocular lens market is poised to reach USD 1.69 billion.

MARKET DRIVERS

Increasing Prevalence of Cataracts in the Aging Population

The use of intraocular lenses has increased due to the increasing prevalence of cataracts in the aging population. The growing adoption of high-end intraocular lenses, such as fitting intraocular lenses and multifocal intraocular lenses, and increasing government initiatives are some of the key factors driving the growth of the APAC IOL market. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.

The increasing prevalence of cataracts, the increasing demand for minimally invasive procedures, and advancements in technology are the major drivers that are significantly boosting the market penetration during the forecast years.

According to the World Health Organization (WHO), around 22 million cataract surgeries have been performed and are expected to reach around 35 million by 2025. The large number of patients and increased government funding. These factors will lead to significant growth in the years to come.

MARKET RESTRAINTS

High Costs Associated with Cataract Treatment

The high costs associated with cataract treatment and the low reimbursement for conventional and advanced surgeries are challenging the growth of the intraocular lens market. The availability of advanced technologies such as micro-incision cataract surgery and femtosecond lasers would create opportunities for the global intraocular lens market. The global intraocular lens market trend is multi-distance vision capability. Post-surgical complications, such as refractive errors and the like, threaten to limit growth.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2024 to 2033

Base Year

2024

Forecast Period

2025 to 2033

Segments Covered

By Material, Type, End user, and Region.

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Countries Covered

India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, Rest Of APAC.

Market Leader Profiled

Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, Oculentis GmBH., and Others.

 

SEGMENT ANALYSIS

By Material Insights

The Silicone segment held the leading share of the Asia Pacific intraocular lens market in 2024.

REGIONAL ANALYSIS

The multiple lucrative opportunities offered by the intraocular lens market in the densely populated APAC regions are expected to drive market growth at the fastest rate during the forecast period. The market in these regions is expected to grow at a profitable rate during the forecast period owing to the increase in the geriatric population and an exponential increase in the diabetic population in these regions, such as China, Taiwan, Singapore, and the Pacific regions etc. Developing economies such as Japan, China, and India are the major contributors to regional market revenues.

China is expected to experience the fastest growth in the Asia-Pacific intraocular lens market in 2024,

China is expected to post the fastest growth rate during the forecast period. The increase in the geriatric population and growing diabetic population in developing countries is leading to increased adoption of cataracts and other retinal procedures, driving the APAC intraocular lens market.

Patients with diabetes are more prone to cataracts, macular degeneration, and other ophthalmic disorders, resulting in an increased need for various types of intraocular lenses. According to the International Diabetes Federation, the Western Pacific region had the largest diabetic population of 78 million, while the East Asia region had 62 million. India accounted for 52.6 million and China 45.7 million of the diabetic population of the latter region.

Massive patient pool and expanding health tourism industry are driving the growth of IOL market in developing countries such as China and India. Additionally, government initiatives to develop and commercialize cost-effective treatment options and the collaborative efforts of private and government entities to establish eye care centers are driving market growth in Asia Pacific during the forecasted period 2024 to 2033.

KEY MARKET PLAYERS

Top companies dominating the Asia Pacific intraocular lens market profiled in the report are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, Oculentis GmBH., and Others.

MARKET SEGMENTATION

This research report on the Asia-Pacific intraocular lens market has been segmented and sub-segmented into the following categories.

By Material

  • Polymethylmethacrylate (PMMA)
  • Silicone
  • Hydrophobic Acrylic

By Type

  • Monofocal Intraocular Lens
  • Premium Intraocular Lens
  • Toric Intraocular Lens
  • Multifocal Intraocular Lens
  • Accommodating Intraocular Lens

By End User

  • Hospitals
  • Ophthalmology Clinics
  • Eye Research Institutes
  • Ambulatory Surgical Centers

By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest Of APAC

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample